Reviews
Vol. 5 No. 3 (2026): In memory of Armando D’Angelo
The expanded universe of thrombin: a comprehensive review of its hemostasis-independent roles and structure-function relationships
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 28 August 2026
0
Views
0
Downloads
Authors
Thrombin, the central protease of the coagulation cascade, has long been recognized for its essential role in hemostasis, converting fibrinogen to fibrin and activating platelets. However, a growing body of evidence over the past two decades has firmly established thrombin as a pluripotent mediator operating at the intersection of coagulation, inflammation, immunity, and tissue repair. This manuscript provides a comprehensive review of the hemostasis- and coagulation-independent functions of thrombin, integrating updated evidence with the sophisticated structure-function relationships that govern these diverse activities. We explore the molecular basis of thrombin’s versatility, focusing on its allosteric regulation by sodium ions, its two anion-binding exosites, and its primary signaling mechanism via protease-activated receptors. The discussion extends to thrombin’s critical roles in neurobiology, where it exhibits a dualistic nature in stroke and neurodegeneration, its profound influence on inflammation and immunity, and its paradoxical involvement in cancer progression and angiogenesis. Furthermore, we highlight emerging concepts, including the discovery of its tissue-specific roles. Understanding these multifaceted functions is crucial for developing targeted therapeutic strategies that can modulate thrombin’s pathological actions without compromising its essential hemostatic functions.
Downloads
Download data is not yet available.
Citations
1. van Rijn JL, Govers-Riemslag JW, Zwaal RF, Rosing J. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry 1984;23:4557-64.
2. Scheraga HA. The thrombin-fibrinogen interaction. Biophys Chem 2004;112:117-30.
3. Naski MC, Lorand L, Shafer JA. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII. Biochemistry 1991;30:934-41.
4. Camire RM, Bos MH. The molecular basis of factor V and VIII procofactor activation. J Thromb Haemost 2009;7:1951-61.
5. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-64.
6. De Candia E, Hall SW, Rutella S, et al. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 2001;276:4692-8.
7. Brass LF. Thrombin and platelet activation. Chest 2003;124:18S-25S.
8. Di Cera E. Thrombin interactions. Chest 2003;124:11S-17S.
9. Di Cera E. Thrombin. Mol Aspects Med 2008;29:203-54.
10. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A 1981;78:2249-52.
11. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995;9:946-55.
12. Dahlback B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol 2005;25:1311-20.
13. De Cristofaro R, Picozzi M, Morosetti R, Landolfi R. Effect of sodium on the energetics of thrombin-thrombomodulin interaction and its relevance for protein C hydrolysis. J Mol Biol 1996;258:190-200.
14. Binette TM, Taylor FB Jr, Peer G, Bajzar L. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon. Blood 2007;110:3168-75.
15. Cirino G, Cicala C, Bucci MR, et al. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 1996;183:821-7.
16. Scaldaferri F, Sans M, Vetrano S, et al. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest 2007;117:1951-60.
17. Garcia PS, Ciavatta VT, Fidler JA, et al. Concentration-dependent dual role of thrombin in protection of cultured rat cortical neurons. Neurochem Res 2015;40:2220-9.
18. Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 2006;10:355-62.
19. Luo W, Wang Y, Reiser G. Two types of protease-activated receptors (PAR-1 and PAR-2) mediate calcium signaling in rat retinal ganglion cells RGC-5. Brain Res 2005;1047:159-67.
20. Fredenburgh JC, Weitz JI. Exosite crosstalk in thrombin. J Thromb Haemost 2025;23:1160-8.
21. Wells CM, Di Cera E. Thrombin is a Na(+)-activated enzyme. Biochemistry 1992;31:11721-30.
22. De Cristofaro R, Di Cera E. Modulation of thrombin-fibrinogen interaction by specific ion effects. Biochemistry 1992;31:257-65.
23. Chen D, Dorling A. Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost 2009;7:122-6.
24. Maggio N, Itsekson Z, Dominissini D, et al. Thrombin regulation of synaptic plasticity: implications for physiology and pathology. Exp Neurol 2013;247:595-604.
25. Bode W, Turk D, Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1992;1:426-71.
26. Karshikov A, Bode W, Tulinsky A, Stone SR. Electrostatic interactions in the association of proteins: an analysis of the thrombin-hirudin complex. Protein Sci 1992;1:727-35.
27. Treuheit NA, Beach MA, Komives EA. Thermodynamic compensation upon binding to exosite 1 and the active site of thrombin. Biochemistry 2011;50:4590-6.
28. Kamath P, Huntington JA, Krishnaswamy S. Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states. J Biol Chem 2010;285:28651-8.
29. Fredenburgh JC, Stafford AR, Weitz JI. Evidence for allosteric linkage between exosites 1 and 2 of thrombin. J Biol Chem 1997;272:25493-9.
30. De Cristofaro R. Effect of thrombomodulin on the molecular recognition and early catalytic events in thrombin-protein C interaction. Thromb Haemost 1996;76:556-60.
31. Bukys MA, Orban T, Kim PY, et al. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII. J Biol Chem 2006;281:18569-80.
32. Myles T, Le Bonniec BF, Stone SR. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1. Eur J Biochem 2001;268:70-7.
33. Malovichko MV, Sabo TM, Maurer MC. Ligand binding to anion-binding exosites regulates conformational properties of thrombin. J Biol Chem 2013;288:8667-78.
34. Handley LD, Treuheit NA, Venkatesh VJ, Komives EA. Thrombomodulin binding selects the catalytically active form of thrombin. Biochemistry 2015;54:6650-8.
35. Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost 2005;3:1861-72.
36. Sheehan JP, Sadler JE. Molecular mapping of the heparin-binding exosite of thrombin. Proc Natl Acad Sci U S A 1994;91:5518-22.
37. Balogh G, Bereczky Z. The effects of heparin binding and Arg596 mutations on the conformation of thrombin-antithrombin Michaelis complex, revealed by enhanced sampling molecular dynamics simulations. Int J Mol Sci 2025;26:9901.
38. Carter WJ, Cama E, Huntington JA. Crystal structure of thrombin bound to heparin. J Biol Chem 2005;280:2745-9.
39. De Candia E, De Cristofaro R, De Marco L, et al. Thrombin interaction with platelet GpIB: role of the heparin binding domain. Thromb Haemost 1997;77:735-40.
40. Izaguirre G. The allosteric communication network in the activation of antithrombin by heparin. Int J Mol Sci 2025;26:8984.
41. Jakobsche-Policht U, Bronowicka-Szydelko A, Adamiec R, et al. The predictive role of protease-activated receptor (PAR-1) polymorphisms and activated microplatelets on the severity of atherosclerosis: preliminary studies. Front Mol Biosci 2025;12:1662954.
42. Flaumenhaft R, De Ceunynck K. Targeting PAR1: now what? Trends Pharmacol Sci 2017;38:701-16.
43. Bae JS, Yang L, Rezaie AR. Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells. J Thromb Haemost 2008;6:954-61.
44. Russo A, Soh UJ, Paing MM, et al. Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc Natl Acad Sci U S A 2009;106:6393-7.
45. Bae JS, Yang L, Manithody C, Rezaie AR. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 2007;110:3909-16.
46. Bae JS, Yang L, Rezaie AR. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci U S A 2007;104:2867-72.
47. Cao C, Gao Y, Li Y, et al. The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. J Clin Invest 2010;120:1971-80.
48. Soh UJ, Trejo J. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through beta-arrestin and dishevelled-2 scaffolds. Proc Natl Acad Sci U S A 2011;108:E1372-80.
49. Festoff BW, Dockendorff C. The evolving concept of neuro-thromboinflammation for neurodegenerative disorders and neurotrauma: a rationale for PAR1-targeting therapies. Biomolecules 2021;11:1522.
50. Jakobsche-Policht U, Bronowicka-Szydelko A, Adamiec R, et al. The role of protease-activated receptors (PARs) in the functioning of platelets and platelet-derived microparticles (PMPs). Front Mol Biosci 2025;12:1636893.
51. Kahn ML, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature 1998;394:690-4.
52. Faruqi TR, Weiss EJ, Shapiro MJ, et al. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J Biol Chem 2000;275:19728-34.
53. Schmidt VA, Nierman WC, Maglott DR, et al. The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets. J Biol Chem 1998;273:15061-8.
54. Iannucci J, Grammas P. Thrombin, a key driver of pathological inflammation in the brain. Cells 2023;12:1248.
55. Strande JL, Phillips SA. Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro. J Inflamm (Lond) 2009;6:4.
56. Li X, Hahn CN, Parsons M, et al. Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1. Blood 2004;104:1716-24.
57. Stahmann N, Woods A, Carling D, Heller R. Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Mol Cell Biol 2006;26:5933-45.
58. Storck J, Kusters B, Zimmermann ER. The tethered ligand receptor is the responsible receptor for the thrombin induced release of von Willebrand factor from endothelial cells (HUVEC). Thromb Res 1995;77:249-58.
59. Sim MMS, Mollica MY, Alfar HR, et al. Unfolded von Willebrand factor binds protein S and reduces anticoagulant activity. Blood Vessel Thromb Hemost 2025;2:100030.
60. Schrottmaier WC, Assinger A. The concept of thromboinflammation. Hamostaseologie 2024;44:21-30.
61. Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD. Interactions between coagulation and complement--their role in inflammation. Semin Immunopathol 2012;34:151-65.
62. Wang W, Wang C, Deng J, et al. Beyond hemostasis, the immunomodulatory nature of platelets. Res Pract Thromb Haemost 2025;9:103182.
63. Varon D, Shai E. Platelets and their microparticles as key players in pathophysiological responses. J Thromb Haemost 2015;13:S40-6.
64. Ye F, Garton HJL, Hua Y, et al. The role of thrombin in brain injury after hemorrhagic and ischemic stroke. Transl Stroke Res 2021;12:496-511.
65. Bao L, Zu J, He Q, et al. Thrombin-induced apoptosis in neurons through activation of c-Jun-N-terminal kinase. Toxicol Mech Methods 2017;27:18-23.
66. Moller T, Hanisch UK, Ransom BR. Thrombin-induced activation of cultured rodent microglia. J Neurochem 2000;75:1539-47.
67. Abdel-Latif RT, El-Abhar HS, Abdallah DM, et al. Dual inhibition of canonical and noncanonical PAR-1 by SCH79797 mitigates neurodegeneration in 3-NP-induced Huntington's disease: an in vivo and in silico approach. Arch Pharm (Weinheim) 2025;358:e2400846.
68. Sokolova E, Reiser G. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost 2008;100:576-81.
69. Savotchenko A, Klymenko M, Shypshyna M, Isaev D. The role of thrombin in early-onset seizures. Front Cell Neurosci 2023;17:1101006.
70. Tsopanoglou NE, Maragoudakis ME. Role of thrombin in angiogenesis and tumor progression. Semin Thromb Hemost 2004;30:63-69.
71. Catar R, Moll G, Hosp I, et al. Transcriptional regulation of thrombin-induced endothelial VEGF induction and proangiogenic response. Cells 2021;10:944.
72. Wilgenbus P, Pott J, Pagel S, et al. Coagulation proteases modulate nucleic acid uptake and cGAS-STING-IFN induction in the tumor microenvironment. JCI Insight 2025;10:e187000.
73. Gugerell A, Pasteiner W, Nurnberger S, et al. Thrombin as important factor for cutaneous wound healing: comparison of fibrin biomatrices in vitro and in a rat excisional wound healing model. Wound Repair Regen 2014;22:740-8.
74. Strukova SM, Dugina TN, Chistov IV, et al. Immobilized thrombin receptor agonist peptide accelerates wound healing in mice. Clin Appl Thromb Hemost 2001;7:325-9.
75. Battafarano G, Lancellotti S, Sacco M, et al. Effects of coagulation factors on bone cells and consequences of their absence in haemophilia A patients. Sci Rep 2024;14:25001.
CRediT authorship contribution
SL, MS, AF, and LDG provided thoughts and insight into thrombin function, controlled the bibliographic references and revised the manuscript, RDC designed and wrote the paper.
Data Availability Statement
The datasets used and/or analyzed during the current study are available upon reasonable request from the corresponding author.
How to Cite
1.
Sacco M, Lancellotti S, Ferretti A, Basso M, Di Gennaro L, De Cristofaro R. The expanded universe of thrombin: a comprehensive review of its hemostasis-independent roles and structure-function relationships. Bleeding Thromb Vasc Biol [Internet]. 2026 Aug. 28 [cited 2026 Aug. 28];5(3). Available from: https://www.btvb.org/btvb/article/view/462
Copyright (c) 2026 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro, The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 1 (2022)
- Alice Lipari, Esmeralda Capristo, Antonietta Ferretti, Erica De Candia, Anticoagulation in obese patients: challenges and strategies , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno, The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Eleonora Petito, Anna Maria Mezzasoma, Emanuela Falcinelli, Chiara Conti, Erica De Candia, Raimondo De Cristofaro, Silvia Sorrentino, Gian Marco Podda, Mariangela Scavone, Anna Falanga, Marina Marchetti, Luca Barcella, Stefania Basili, Lucia Stefanini, Andrea Boccatonda, Laura Contino, Patrizia Sciancalepore, Igor Florio, Egidio Imbalzano, Rossella Marcucci, Angela Rogolino, Patrizia Noris, Marta Panella, Rita Santoro, Maria Costanza Turi, Gaetano Vaudo, Rosa Curcio, Paolo Gresele, Persistence of functional anti-PF4 antibodies and neutrophil activation in vaccine-induced immune thrombotic thrombocytopenia , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Tiziano Martini, Alessandra Valpreda, Marina Marchetti, Alberto Catalano, Laura Contino, Raimondo De Cristofaro, Augusto Bramante Federici, Ilaria Quaglia, Rossana Rossi, Rita Carlotta Santoro, Armando Tripodi, Angelo Claudio Molinari, Diagnostic challenges in current laboratory practice at Italian Hemophilia Centers: findings from a nationwide survey , Bleeding, Thrombosis and Vascular Biology: Vol. 5 No. 1 (2026)
- Franco Piovella, Björn Dahlbäck, Raimondo De Cristofaro, Jim Morrissey, Bruce L. Davidson, Stefanie Mahan, Hugo ten Cate, Alex Spyropoulos, Charles Mahan, Charles T. Esmon, Valerio De Stefano, Francesco Bernardi, In memoriam of Prof. Armando D’Angelo (1952-2024) , Bleeding, Thrombosis and Vascular Biology: Vol. 5 No. 3 (2026): In memory of Armando D’Angelo
